← Back to all signals
RESEARCH PAPER ANALYSIS

Gross motor function, functional level, physical performance, and muscle strength in preschool children newly diagnosed with cancer: Data from the RePlay trial.

In baseline cross-sectional data from 83 children aged 1–5 years newly diagnosed with cancer, most showed below-average gross motor function, mobility, and handgrip strength relative to age-expected normative values, while some physical-performance and strength assessments had limited feasibility.

Open original publication →
PMID42608598
JournalEuropean journal of pediatrics
Publication Date2026-08-18
Ingested2026-08-20 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

In baseline cross-sectional data from 83 children aged 1–5 years newly diagnosed with cancer, most showed below-average gross motor function, mobility, and handgrip strength relative to age-expected normative values, while some physical-performance and strength assessments had limited feasibility.

WHY IT MATTERS

Research significance

The study provides evidence that functional impairments are already present near cancer diagnosis in many preschool children; it is reasonable—but not tested here—to hypothesize that early, developmentally tailored physical rehabilitation could preserve or improve motor function, mobility, and strength during treatment.

ABSTRACT

Source abstract

UNLABELLED: Children with cancer experience treatment-related physical disruptions; however, these disruptions for preschool children newly diagnosed with cancer are poorly characterized. This study aimed to quantify gross motor function, functional level, physical performance, and muscle strength in preschool children aged 1-5 years newly diagnosed with cancer, and to compare these with age-expected normative values. This cross-sectional study includes data from the baseline assessment of 83 children (49% girls, 39 ± 16 months old) enrolled in the Rehabilitation including structured active Play for preschoolers with cancer (RePlay) trial. Gross motor function was evaluated using the Peabody Developmental Motor Scales-Second Edition (PDMS-2); functional level was assessed using the Pediatric Evaluation of Disability Inventory (PEDI); physical performance was assessed using the 6-min walk test; and muscle strength was assessed using the KLS Martin Vigorimeter for handgrip strength. Mean gross motor quotient was 78.9 [95% CI: 73.6-84.2], indicating poor overall performance; 76% of the children performed below average or worse. Most children had difficulties with locomotion, with a mean standard score of 5.7 [95% CI: 4.8-6.6], indicating poor performance; 81% of the children performed below average or worse. PEDI mobility data were available for 83 children, with a mean normative standard score of 23.2 [95% CI: 20.0-26.3], indicating decreased functional level; 69% of the children scored below average. Mean handgrip strength was below average compared to healthy children; 0.17 [95% CI: 0.12-0.22]. CONCLUSION: These results show that preschoolers newly diagnosed with cancer have gross motor function, functional level, and muscle strength impairments, underlining the importance of targeted physical rehabilitation. CLINICALTRIALS: gov: NCT04672681. WHAT IS KNOWN: • Research has shown that children newly diagnosed with cancer have markedly impaired muscle strength, cardiorespiratory fitness, physical performance, and gross motor functions. • Gross motor function development is fundamentally important for preschoolers. However, research on gross motor function in children with cancer is limited, and existing studies often include broad age ranges (1-18 years), hindering clear evidence specific to preschoolers aged 1-5 years. WHAT IS NEW: • Preschool children newly diagnosed with cancer have clinically significant impairments of gross motor function and functional level. • Data on physical performance and muscle strength are limited, indicating poor feasibility for preschoolers with cancer.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Serological Evaluation of Anti- FSH Antibody and Anti- LH antibody In Iraqi Women with Polycystic Ovarian Syndrome. F1000Research 62.66 2 Deaths: Leading Causes for 2024. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 57.5 3 Association between hematopoietic recovery indicators and minimal residual disease after induction therapy in newly diagnosed pediatric acute myeloid leukemia. Frontiers in medicine 64.74 4 Methylprednisolone sodium succinate combined with azithromycin in the treatment of Mycoplasma pneumonia in children and Its effect on immune function. Frontiers in pediatrics 67.54 5 Potential of isotoxic dose escalation with robustly optimized VMAT and IMPT for large hepatocellular carcinoma according to baseline liver function. Journal of applied clinical medical physics 80.42 6 Lifestyle Behaviors and Physical Health in Canadian Childhood, Adolescent, and Young Adult Cancer Survivors. Cancer medicine 58.7 7 Assessment of Selected Immunophenotypic Markers in Childhood Non-Hodgkin's Lymphomas in Ghana: A Possible Tool for Effective Stratification of Patients and Assessment of Survival Outcomes. Cancer reports (Hoboken, N.J.) 70.02 8 Establishing environmental causes of childhood cancer: a view from the IARC Monographs. UCL open. Environment 63.0 9 Chatbot Intervention and Cancer Risk Knowledge in Adolescents and Young Adults With Cancer Predisposition: A Randomized Clinical Trial. JAMA network open 73.7 10 Qualitative Exploration of Fertility-Related Attitudes and Perspectives Among Young Adult Women Diagnosed With Breast Cancer at Periurban Cancer Center in Uganda. JCO global oncology 61.1 11 Rare aetiologies of leg ulcers: a prospective analysis. Journal of wound care 65.8 12 Clinically actionable genetic findings by exome sequencing performed for therapeutic purposes in children with very-high risk cancer included the MAPPYACTS study. European journal of cancer (Oxford, England : 1990) 71.54 13 Rapid Whole Genome Sequencing Enhances Pediatric Cancer Diagnosis. Nature communications 66.6 14 Cardiopulmonary exercise testing to measure cardiorespiratory fitness in childhood cancer survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 47.5 15 Age- and latency-specific patterns of subsequent malignant brain and other nervous system tumors after cancer diagnosed before age 40 years. Cancer causes & control : CCC 56.0 16 Impact of Extent of Surgical Resection on Survival in Patients With High-risk Neuroblastoma: A Report From Children's Oncology Group ANBL0532. Annals of surgery 71.72 17 Routine Serologic Duffy Testing in Pediatric Oncology: Clinical Utility and Feasibility in a Single-Center Cohort. Pediatric blood & cancer 79.0 18 Exercise Capacity, Physical Activity, Fatigue, and Neurocognitive Function in Adult Survivors of Childhood Acute Lymphoblastic Leukemia. Pediatric blood & cancer 61.0 19 "We Cannot Talk as a Family": Complexities of Survivorship Communication Among Hispanic/Latino Young Adult Survivors of Childhood Cancer, Parents, and Clinicians. Pediatric blood & cancer 59.6 20 Textbook Outcome in Pediatric Nephroblastoma Surgery After Neoadjuvant Chemotherapy: Defining Standards, Introducing Near-Miss, and Predictors of Failure. Pediatric blood & cancer 73.54 21 Parents of Youth With Cancer Report on Their Psychosocial Care: iSTEPPP Survey Finds Alignment and Gaps With Standards. Pediatric blood & cancer 61.9 22 Skipping of Exon 38 in Neurofibromatosis Type 1 Gene Is Not a Pathogenic Variant. Pediatric blood & cancer 54.0 23 Evidence-Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource-Sensitive Recommendations for the Asian Continent. Pediatric blood & cancer 67.4 24 Obesity's Impact on Prognosis in Ph-Like Acute Lymphoblastic Leukemia. Pediatric blood & cancer 61.2 25 Occupation and Lymphoma Risk by Cell of Origin: A Nationwide Matched Case-Control Study in Thailand. Cancer prevention research (Philadelphia, Pa.) 69.0 26 Cardioneuromodulation for Recurrent Malignant Neurocardiogenic Syncope in Pediatric Patients: Results from a Tertiary Center. Pediatric cardiology 61.5 27 Invasive Pneumococcal Disease in Children: A Retrospective Three-Center Study in Zhejiang Province, China (2010-2024). Infectious diseases and therapy 66.1 28 Speciation-informed Bayesian assessment of metal(loid) exposure from Akora River fish, Ghana, for consumption guidance. Environmental monitoring and assessment 58.4 29 Clinical characteristics, anatomical distribution, and diagnostic patterns of simple bone cysts in Japan: an analysis of the Japanese Bone and Soft Tissue Tumor registry. International journal of clinical oncology 66.9 30 Pathological fracture as initial manifestation of malignancy and survival based on diagnoses: a register-based cohort study from the Swedish Fracture Register and the Swedish Cancer Register. Acta orthopaedica 66.52 31 Melanoma Prevention Among Children of Melanoma Survivors: A Randomized Clinical Trial. JAMA dermatology 78.0 32 Causal estimation and machine learning methods for survival outcomes among AYA cancer patients: A scoping review. Cancer epidemiology 67.02
PATIENT-FRIENDLY SUMMARY

Gross motor function, functional level, physical performance, and muscle strength in preschool children newly diagnosed with cancer: Data from the RePlay trial.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic